Beam Therapeutics (BEAM) Depreciation & Amortization (IS): 2024-2025
Historic Depreciation & Amortization (IS) for Beam Therapeutics (BEAM) over the last 2 years, with Sep 2025 value amounting to $5.6 million.
- Beam Therapeutics' Depreciation & Amortization (IS) rose 1.55% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year change of. This contributed to the annual value of $21.9 million for FY2024, which is 9.56% up from last year.
- Per Beam Therapeutics' latest filing, its Depreciation & Amortization (IS) stood at $5.6 million for Q3 2025, which was up 0.40% from $5.5 million recorded in Q2 2025.
- Beam Therapeutics' 5-year Depreciation & Amortization (IS) high stood at $5.6 million for Q2 2024, and its period low was $5.4 million during Q1 2024.
- In the last 2 years, Beam Therapeutics' Depreciation & Amortization (IS) had a median value of $5.5 million in 2025 and averaged $5.5 million.
- Examining YoY changes over the last 5 years, Beam Therapeutics' Depreciation & Amortization (IS) showed a top increase of 1.79% in 2025 and a maximum decrease of 0.68% in 2025.
- Over the past 2 years, Beam Therapeutics' Depreciation & Amortization (IS) (Quarterly) stood at $5.4 million in 2024, then climbed by 1.55% to $5.6 million in 2025.
- Its Depreciation & Amortization (IS) stands at $5.6 million for Q3 2025, versus $5.5 million for Q2 2025 and $5.5 million for Q1 2025.